Hong Kong-led study discovers simeprevir as potent treatment for COVID-19 1 Special: Battle Against Novel Coronavirus

A Hong Kong-led global study showed that a hepatitis C virus drug simeprevir can strongly suppress the replication of SARS-CoV-2, the virus that causes COVID-19, according to a press release issued by the Chinese University of Hong Kong (CUHK) on Monday.…

This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.